LCN2 and acute kidney injury: Moreover, the identification of key biomarkers, such as neutrophil gelatinase-associated lipocalin (NGAL) and procalcitonin, has advanced the early diagnosis of AKI, aiding in timely intervention and better patient outcomes [9,10].